131 related articles for article (PubMed ID: 12084983)
21. Inverse relationship of expression between GM3 and globo-series ganglioside in human renal cell carcinoma.
Saito S; Nojiri H; Satoh M; Ito A; Ohyama C; Orikasa S
Tohoku J Exp Med; 2000 Apr; 190(4):271-8. PubMed ID: 10877509
[TBL] [Abstract][Full Text] [Related]
22. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
[TBL] [Abstract][Full Text] [Related]
23. A series of disialogangliosides with binary 2----3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens.
Nudelman ED; Mandel U; Levery SB; Kaizu T; Hakomori S
J Biol Chem; 1989 Nov; 264(31):18719-25. PubMed ID: 2509467
[TBL] [Abstract][Full Text] [Related]
24. Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration.
Wasco MJ; Pu RT
Diagn Cytopathol; 2008 Aug; 36(8):568-73. PubMed ID: 18618717
[TBL] [Abstract][Full Text] [Related]
25. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
26. Four new human renal cell carcinoma cell lines expressing globo-series gangliosides.
Satoh M; Nejad FM; Nakano O; Ito A; Kawamura S; Ohyama C; Saito S; Orikasa S
Tohoku J Exp Med; 1999 Oct; 189(2):95-105. PubMed ID: 10775053
[TBL] [Abstract][Full Text] [Related]
27. Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications.
Bakshi N; Kunju LP; Giordano T; Shah RB
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):310-5. PubMed ID: 17721277
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen.
Cooling L; Hwang D
Transfusion; 2005 May; 45(5):709-16. PubMed ID: 15847659
[TBL] [Abstract][Full Text] [Related]
29. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells.
Fenderson BA; Andrews PW; Nudelman E; Clausen H; Hakomori S
Dev Biol; 1987 Jul; 122(1):21-34. PubMed ID: 3297853
[TBL] [Abstract][Full Text] [Related]
30. A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a murine monoclonal antibody.
Kochevar J
Cancer; 1987 Jun; 59(12):2031-6. PubMed ID: 3552200
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney.
Oosterwijk E; Ruiter DJ; Hoedemaeker PJ; Pauwels EK; Jonas U; Zwartendijk J; Warnaar SO
Int J Cancer; 1986 Oct; 38(4):489-94. PubMed ID: 2428759
[TBL] [Abstract][Full Text] [Related]
32. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
Gokden N; Gokden M; Phan DC; McKenney JK
Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
[TBL] [Abstract][Full Text] [Related]
33. [Renal cancer specific antitumor activities of a mouse monoclonal antibody K2.7 to human renal cell carcinoma].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1992 Nov; 38(11):1325-31. PubMed ID: 1485589
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
35. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
[TBL] [Abstract][Full Text] [Related]
36. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression.
Ito A; Handa K; Withers DA; Satoh M; Hakomori S
FEBS Lett; 2001 Jun; 498(1):116-20. PubMed ID: 11389909
[TBL] [Abstract][Full Text] [Related]
37. Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.
van Dijk J; Warnaar SO; van Eendenburg JD; Thienpont M; Braakman E; Boot JH; Fleuren GJ; Bolhuis RL
Int J Cancer; 1989 Feb; 43(2):344-9. PubMed ID: 2521843
[TBL] [Abstract][Full Text] [Related]
38. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
Ozawa H; Kawashima I; Tai T
Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
[TBL] [Abstract][Full Text] [Related]
39. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
40. Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell Carcinoma.
Maekawa M; Sato T; Kanno C; Sakamoto I; Kawasaki Y; Ito A; Mano N
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
